IMI2 Call 21 on COVID19 – deadline: 31 March 2020

The Innovative Medicines Initiative (IMI) announced a call for research proposals (deadline: 31 March 2020) that aims to support projects that develop treatments and diagnostics to better tackle the COVID19 outbreak and to increase preparedness for possible future outbreaks. Please find further details on the official website of the call.
Please be aware that this is a single stage submission (70 pages), meaning the pharma partners have to be contacted already now for the consortium. Please find all additional special requirements are in the published FAQ of IMI.